Organization
Areteia Therapeutics
4 clinical trials
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic AsthmaStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
An Open-Label Long-Term Phase III Extension Study to Assess the Long-Term Safety and Tolerability of Dexpramipexole in Participants With Severe Eosinophilic AsthmaStatus: , Estimated PCD: 2027-06-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 24 Weeks in Participants With Eosinophilic AsthmaStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic AsthmaStatus: Recruiting, Estimated PCD: 2026-06-01